HigoSense Raises Series A Funding Led by Cogito Capital Partners
HigoSense, a Warsaw-based digital healthcare provider announced a €5 million Series A funding round led by Cogito Capital Partners with participation from existing early-stage investors, the founders of RTB House.
December 20, 2021
HigoSense, a Warsaw-based digital healthcare provider announced a €5 million Series A funding round led by Cogito Capital Partners with participation from existing early-stage investors, the founders of RTB House.
HigoSense, founded in 2017 by a team of serial entrepreneurs and medtech specialists, is a provider of a mobile medical examination device supported by a mobile app and an online AIpowered health diagnostic platform. The Company enables physicians to perform a highquality remote patient examination, and patients to perform a self-examination and collect diagnostic data prior to or during a telehealth session.
The Series A funding will help the Company continue to expand its solution in new markets across Europe, the Middle East and Asia.
The HigoSense device is a modular examination tool consisting of a primary device and five extension modules, each dedicated to different diagnostic functions: thermometer, throat spatula, stethoscope, otoscope and derm hood, enabling the patients and doctors to remotely examine body temperature, throat, heart, lungs, ears, and skin.
Higo Mobile App guides the patients and physicians step-by-step through the medical examination with the Higo device and gives instant access to their health records. The Company also offers a telehealth platform integrated with the device, where patient data is stored; the platform includes the Higo Doctor Portal enabling physicians to interpret video, audio, and interview data.
The software behind the device and the platform is powered by AI-enabled algorithms enhancing patient experience and supporting physicians in their analysis of medical data collected.
The telemedicine market has seen a rapid growth during the pandemic, as patient and doctor acceptance of the technology for conducting routine medical consultations has soared. According to Graphical Research, the size of telemedicine market in Europe is expected to grow from $12.8Bn in 2019 to $49.1Bn in 2026. By enabling a comprehensive and guided remote examination, HigoSense significantly expands the range of conditions and symptoms that can now be reliably diagnosed during a telehealth session, which is one of the most important current issues for both the patients and healthcare providers. Łukasz Krasnopolski, the Founder and CEO of HigoSense said: “At Higo, our mission is to deliver both, enhanced patient experience and improved efficiency for healthcare providers. With Higo device and AI-powered health diagnostic platform we enable a remote examination that combines the advantages of telehealth session and in-person appointment”.
Sylwester Janik, General Partner at Cogito said: “We are excited to partner with Łukasz and Michał to support HigoSense’s product and market expansion plans as the industry matures and continues its rapid growth. Telemedicine redefines the way health systems operate and how we all get health care and Higo delivers the missing part of the telehealth value chain” .
Since it was founded in 2017, HigoSense has raised €8 million and launched commercially its medical device in Europe, and the current round brings the company’s total capital raised to more than €13 million.
About HigoSense
HigoSense is a Warsaw, Poland-based provider of a mobile medical examination device supported by a mobile app and an online AI-powered health diagnostic platform. The Company enables physicians to perform a high-quality remote patient examination as well patients to perform a self-examination and collect diagnostic data prior to or during a telehealth session. For further information about HigoSense, please visit our website https://higosense.com/
Contact:
About Cogito Capital Partners
Cogito Capital Partners is a venture capital firm based in Warsaw, Poland and New York, USA. Cogito invests primarily in late-stage tech companies operating in European countries, but with global expansion potential. Cogito focuses on key B2B technology sectors: enterprise software, fintech and digital health, partnering with entrepreneurs seeking investors with CEE regional presence and global reach. For further information about Cogito, please visit our website http://cogitocap.com/